Pharmaceutical Technology on MSN
BIO 2026: NVIDIA announces the BioNeMo toolkit for AI agents
The suite of tools is designed to allow AI to carry out R&D work more quickly, reliably, and in a continuous innovation loop.
The Multi-Agent Bio-Robotics (MABL) laboratory is a research laboratory led by Dr. Ferat Sahin. MABL is on the cutting edge of robotics research and aims to push that boundary further. At MABL, ...
Industry and research leaders including Dassault Systèmes, Databricks, Lilly, OpenAI, Schrödinger, Snowflake, the UW Medicine ...
OpenAI has officially classified its new ChatGPT Agent as a high bio-risk tool, citing concerns about its potential misuse in the creation of biological or chemical weapons. The decision marks the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results